Two-Dose Methotrexate for Ectopic Pregnancy
Ectopic Pregnancy
About this trial
This is an interventional treatment trial for Ectopic Pregnancy focused on measuring Ectopic pregnancy, Methotrexate
Eligibility Criteria
Inclusion Criteria: Confirmed diagnosis of ectopic pregnancy via D&E without products of conception identified on frozen pathology or VABRA without products of conception identified with pathologic evaluation or Ultrasound visualization of a gestational sac in the adnexa, with definitive visualization of a yolk sac or fetal pole the subject is hemodynamically stable without signs of hemoperitoneum laparoscopy has not been performed the subject is able to return for frequent follow-up care normal renal and liver function have been documented within 2 days normal white blood count and platelet count have been documented as per laboratory standard normal chest x-ray was obtained if the subject has a history of pulmonary disease no history of allergy or sensitivity to methotrexate or any component of its formulation Exclusion Criteria: breastfeeding laboratory evidence of immunodeficiency alcoholism or chronic liver disease the concomitant use of non-steroidal anti-inflammatory drugs blood dyscrasia such as leukopenia, thrombocytopenia, or severe anemia active pulmonary disease hepatic, renal, or hematological dysfunction adnexal mass > or = 3.5 cm presence of fetal cardiac motion active major psychiatric disorder such as major depression, bipolar disease, psychotic disorder, or drug addiction subjects unable or unwilling to comply with study procedures or illiterate
Sites / Locations
- University of Southern California Women's and Children's Hospital
- University of Miami
- University of Pennsylvania Reproductive Research Unit